The magnetic resonance imaging contrast agent mangafodipir exerts antitumor activity via a previously described superoxide dismutase mimetic activity.
Karlsson, Jan Olof G
The magnetic resonance imaging contrast agent mangafodipir exerts antitumor activity via a previously described superoxide dismutase mimetic activity. [electronic resource] - Cancer research Jan 2006 - 598; author reply 598 p. digital
Publication Type: Comment; Letter
0008-5472
10.1158/0008-5472.CAN-05-2053 doi
Antineoplastic Agents--pharmacology
Biomimetic Materials--pharmacology
Contrast Media--pharmacology
Edetic Acid--analogs & derivatives
Hydrogen Peroxide--metabolism
Pyridoxal Phosphate--analogs & derivatives
Superoxide Dismutase--metabolism
The magnetic resonance imaging contrast agent mangafodipir exerts antitumor activity via a previously described superoxide dismutase mimetic activity. [electronic resource] - Cancer research Jan 2006 - 598; author reply 598 p. digital
Publication Type: Comment; Letter
0008-5472
10.1158/0008-5472.CAN-05-2053 doi
Antineoplastic Agents--pharmacology
Biomimetic Materials--pharmacology
Contrast Media--pharmacology
Edetic Acid--analogs & derivatives
Hydrogen Peroxide--metabolism
Pyridoxal Phosphate--analogs & derivatives
Superoxide Dismutase--metabolism